Long‐Term Oncological Outcome Comparison between Intermediate‐and High‐Dose Radioactive Iodine Ablation in Patients with Differentiated Thyroid Carcinoma: A …
K Kim, JS Bae, JS Kim - International Journal of Endocrinology, 2021 - Wiley Online Library
Background. Radioactive iodine (RAI) ablation is recommended for most patients with
differentiated thyroid carcinoma (DTC) after total thyroidectomy (TT). We aimed to compare …
differentiated thyroid carcinoma (DTC) after total thyroidectomy (TT). We aimed to compare …
Outcomes after radioiodine ablation in patients with thyroid cancer: Long‐term follow‐up of a Chinese randomized clinicaltrial
P Dong, Y Qu, L Yang, L Xiao, R Huang… - Clinical …, 2021 - Wiley Online Library
Objective Two large randomized trials of patients with differentiated thyroid cancer (DTC)
reported recently (HiLo and ESTIMABL1) found that the recurrence rate among patients who …
reported recently (HiLo and ESTIMABL1) found that the recurrence rate among patients who …
Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer
Y Iizuka, T Katagiri, K Ogura, T Mizowaki - Annals of Nuclear Medicine, 2019 - Springer
Objective This study aimed to compare the clinical outcomes of patients who received
radioactive iodine (RAI) ablation after undergoing thyroidectomy for intermediate-to-high-risk …
radioactive iodine (RAI) ablation after undergoing thyroidectomy for intermediate-to-high-risk …
Radioiodine versus no radioiodine outcomes in low‐risk differentiated thyroid cancers: A propensity‐score matched analysis
S Satapathy, A Tupalli, KR Chandekar… - Clinical …, 2023 - Wiley Online Library
Abstract Objective The 2015 American Thyroid Association guidelines recommend against
radioiodine (RAI) ablation for patients with low‐risk papillary microcarcinoma. However, its …
radioiodine (RAI) ablation for patients with low‐risk papillary microcarcinoma. However, its …
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients
C Schvartz, F Bonnetain, S Dabakuyo… - The Journal of …, 2012 - academic.oup.com
Context: American Thyroid Association and European Thyroid Association guidelines
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …
cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk …
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer
L Welsh, C Powell, B Pratt, K Harrington… - The Journal of …, 2013 - academic.oup.com
Context: Randomized trials show that low-dose (1.1 GBq [30 mCi]) radioiodide (RAI) has
efficacy equivalent to high-dose RAI (3.7 GBq [100 mCi]) in thyroid remnant ablation (TRA) …
efficacy equivalent to high-dose RAI (3.7 GBq [100 mCi]) in thyroid remnant ablation (TRA) …
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
MG Castagna, G Cevenini… - European journal of …, 2013 - academic.oup.com
Background In differentiated thyroid cancer (DTC) patients at intermediate risk of
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …
recurrences, no evidences are provided regarding the optimal radioactive iodine (RAI) …
Radioactive iodine ablation post differentiated thyroid cancer surgery: an analysis of use and impact of the American Thyroid Association guidelines
Y Sia, RV Dave, D Nour, JA Miller… - ANZ Journal of …, 2019 - Wiley Online Library
Abstract Background The 2009 American Thyroid Association (ATA) three‐tiered risk
stratification, and its updated version in 2015, provided clearer guidance on the use of …
stratification, and its updated version in 2015, provided clearer guidance on the use of …
[HTML][HTML] Re-treatment with adjuvant radioactive iodine does not improve recurrence-free survival of patients with differentiated thyroid cancer
C Bouvet, B Barres, F Kwiatkowski… - Frontiers in …, 2019 - frontiersin.org
Introduction: Loco regional persistence or recurrence of differentiated thyroid cancer (DTC)
is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this …
is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this …
Intermediate‐risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long‐term outcome study
S Ballal, R Soundararajan, A Garg… - Clinical …, 2016 - Wiley Online Library
Objective The mute question is whether patients with DTC of intermediate risk of recurrence,
second most common presentation, who were surgically ablated in the first place, ever …
second most common presentation, who were surgically ablated in the first place, ever …
相关搜索
- thyroid carcinoma high dose
- radioactive iodine ablation
- propensity score thyroid cancers
- high dose radioiodine ablation
- overall survival radioactive iodine
- iodine ablation high risk
- risk patients recurrence rate
- thyroid cancer recurrence rate
- radioiodine ablation in patients
- meta analysis recurrence rate
- post-surgical thyroid ablation
- low and intermediate risk patients
- thyroid ablation radioiodine activities
- thyroid cancer survival of patients
- risk patients meta analysis
- iodine ablation high dose